Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- Check4 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check11 days agoChange DetectedItaly location entry updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedNaples, Campania, Italy, 80131 was added and Napoli, Campania, Italy, 80131 was removed from the location list. The update aligns site naming with English-language conventions and improves site identification for users.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now states that the trial was terminated globally (excluding US and Greater China) with results posted, and it adds details showing 74 study locations.SummaryDifference2%

- Check69 days agoChange DetectedRevision: v3.4.2 has been added; the notices about a lapse in government funding and Revision: v3.4.1 have been removed. These are minor site maintenance changes and do not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.